
Photo taken from ESTRO/LinkedIn
Aug 11, 2024, 13:07
Targeting serine/glycine metabolism with sertraline can enhance radiotherapy responses in NSCLC – ESTRO
European Society for Radiotherapy and Oncology (ESTRO) shared on LinkedIn:
“Pre-clinical findings presented at ESTRO24 reveal that targeting serine/glycine metabolism with sertraline can enhance radiotherapy responses in NSCLC (non-small cell lung cancer). This approach radiosensitises the tumor and reduces immune suppression.”
Read further.
Source: ESTRO/LinkedIn
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 29, 2025, 10:55
Mar 29, 2025, 10:45
Mar 29, 2025, 10:11
Mar 29, 2025, 09:47
Mar 29, 2025, 09:26
Mar 29, 2025, 09:13